Merck KGaA (FRA:MRK) received a €103.00 ($110.75) price target from investment analysts at Morgan Stanley in a research report issued to clients and investors on Friday. The firm currently has a a “neutral” rating on the stock.

Several other analysts also recently weighed in on MRK. DZ Bank AG reiterated a “buy” rating on shares of Merck KGaA in a research report on Thursday, July 14th. equinet AG set a €85.00 ($91.40) target price on Merck KGaA and gave the stock a “buy” rating in a research report on Monday, July 18th. Bankhaus Lampe set a €102.00 ($109.68) target price on Merck KGaA and gave the stock a “buy” rating in a research report on Tuesday, July 19th. JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Merck KGaA in a research report on Thursday, July 21st. Finally, Berenberg Bank set a €101.00 ($108.60) target price on Merck KGaA and gave the stock a “buy” rating in a research report on Friday, July 22nd. One equities research analyst has rated the stock with a sell rating, twelve have assigned a hold rating and ten have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of €101.50 ($109.14).

Analyst Recommendations for Merck KGaA (FRA:MRK)

Shares of Merck KGaA (FRA:MRK) opened at 96.19 on Friday. The stock has a market capitalization of €41.82 billion and a P/E ratio of 30.10. Merck KGaA has a 12 month low of €70.87 and a 12 month high of €100.00. The company’s 50-day moving average is €95.68 and its 200 day moving average is €92.81.

Merck KGaA Company Profile

.

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.